Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Daiichi Sankyo
Medtronic
AstraZeneca
US Department of Justice
Citi
Julphar
Queensland Health
Dow

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077793

« Back to Dashboard

NDA 077793 describes PRAVASTATIN SODIUM, which is a drug marketed by Accord Hlthcare, Apotex Inc, Appco Pharma Llc, Aurobindo Pharma Ltd, Cipla Ltd, Dr Reddys Labs Inc, Glenmark Generics, Lupin Pharms, Mylan, Mylan Pharms Inc, Pliva Hrvatska Doo, Ranbaxy Labs Ltd, Sandoz, Teva, Teva Pharms, Watson Labs, and Zydus Pharms Usa, and is included in eighteen NDAs. It is available from forty-seven suppliers. Additional details are available on the PRAVASTATIN SODIUM profile page.

The generic ingredient in PRAVASTATIN SODIUM is pravastatin sodium. There are sixteen drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the pravastatin sodium profile page.
Summary for 077793
Tradename:PRAVASTATIN SODIUM
Applicant:Teva Pharms
Ingredient:pravastatin sodium
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 077793
Medical Subject Heading (MeSH) Categories for 077793
Suppliers and Packaging for NDA: 077793
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PRAVASTATIN SODIUM pravastatin sodium TABLET;ORAL 077793 ANDA Teva Pharmaceuticals USA Inc 0093-7270 N 0093-7270-10
PRAVASTATIN SODIUM pravastatin sodium TABLET;ORAL 077793 ANDA Teva Pharmaceuticals USA Inc 0093-7270 N 0093-7270-98

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength80MG
Approval Date:Jan 15, 2008TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Daiichi Sankyo
Julphar
Farmers Insurance
Cantor Fitzgerald
Citi
Fuji
Harvard Business School
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.